Molecular Determinants of Ethionamide Resistance in Clinical Isolates of Mycobacterium tuberculosis
Sign Up to like & getrecommendations! Published in 2022 at "Antibiotics"
DOI: 10.3390/antibiotics11020133
Abstract: Background: Ethionamide and prothionamide are now included in group C of the WHO recommended drugs for the treatment of tuberculosis resistant to rifampicin and multidrug-resistant tuberculosis. The clinical relevance of ethionamide and prothionamide has increased… read more here.
Keywords: clinical isolates; tuberculosis; ethionamide resistance; molecular determinants ... See more keywords